Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Intangibles (2020 - 2022)

Ovid Therapeutics (OVID) has disclosed Intangibles for 2 consecutive years, with $263000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Intangibles fell 30.05% year-over-year to $263000.0, compared with a TTM value of $263000.0 through Dec 2021, down 30.05%, and an annual FY2021 reading of $263000.0, down 30.05% over the prior year.
  • Intangibles was $263000.0 for Q4 2021 at Ovid Therapeutics, up from $227000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $436000.0 in Q1 2020 and bottomed at $227000.0 in Q2 2021.